E
Enko Chem
Develops novel products for farmers to protect their crops from pests and disease
About Enko Chem
Enko is a crop health company that operates in the agricultural sector, aiming to revolutionize the way crops are grown worldwide. The company's primary clients are farmers who are looking for safer, more sustainable, and environmentally friendly solutions for crop production. Enko's business model is centered around the use of virtual screening to increase efficiency, reduce costs, and improve outcomes in crop production.
The company's mission is to help farmers meet the increasing global demand for food, driven by rapid population growth and rising consumption, without causing harm to the planet. Enko's approach is designed to adapt to and mitigate the effects of climate change, which is crucial for providing safe, affordable, and healthy food to a growing population.
Enko's approach to crop health also addresses the challenges of balancing the global food and fiber system's competing pressures and demands. The company encourages innovative thinking and is committed to setting new industry standards in safety, sustainability, and environmental impact.
Enko generates revenue by selling its crop health solutions to farmers. The company's emphasis on safety, sustainability, and environmental impact could potentially attract a broad range of clients who are conscious about these issues and are looking for effective solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Stonington, United States
- Employees
- 55
- Open positions
- None listed
- Dealroom signal
- 69.1/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Crop Protection, Sustainable Development Goals, Climate Tech, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Jan 2023 | $10M | $350M | Nufarm · Akroyd · Endeavor8 · Eight Roads Ventures | ↗ |
| SERIES COther financing | Jul 2022 | $70M | $320M | Anterra Capital · Bill & Melinda Gates Foundation · Germin8 Ventures · TO Ventures | ↗ |
Growth signals
Latest recorded traffic for Enko Chem is 3.5K monthly website visits, up 150% over the last three months. Enko Chem's team declined 1.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Bill & Melinda Gates Foundation
Anterra Capital
Finistere Ventures
Germin8 Ventures
Bits x Bites
Novalis Lifesciences
Rabobank
Series B and later7 investors entered at this stage
Nufarm- TVTO Ventures
Eight Roads Ventures
Alumni Ventures
Endeavor8- TGTaher Gozal
- AKAkroyd
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Enko Chem on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enko Chem’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.